Brevilin A, a natural product isolated and purified from the herbs of Centipeda minima, is a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs.
We use some essential cookies to make this website work. These cookies aren't used to track you. We'd
like
to set additional cookies to understand how you use our website. This information is used to improve
our
services.